Details of the Drug | DrugMAP

General Information of Drug (ID: DMSAGVN)

Drug Name

TY-51924

Indication

Disease Entry	ICD 11	Status	REF
Myocardial infarction	BA41-BA43	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C14H19N4NaO5S
Canonical SMILES: CC1=C(C=C2CCCCC(C2=N1)COS(=O)(=O)O)C(=NC(=N)N)[O-].[Na+]
InChI: 1S/C14H20N4O5S.Na/c1-8-11(13(19)18-14(15)16)6-9-4-2-3-5-10(12(9)17-8)7-23-24(20,21)22;/h6,10H,2-5,7H2,1H3,(H,20,21,22)(H4,15,16,18,19);/q;+1/p-1
InChIKey: ZLKLPVRVDNGUND-UHFFFAOYSA-M

Cross-matching ID

PubChem CID: 132567298
TTD ID: D08VVR

References

1	Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention. J Cardiol. 2014 Jan;63(1):82-7.